Core Viewpoint - Corning Jereh Pharmaceutical-B (09966) announced a share buyback program with a maximum amount of HKD 20 million, reflecting the board's confidence in the company's business outlook and intrinsic value [1] Summary by Relevant Sections Share Buyback Authorization - The board resolved to repurchase shares from the open market, subject to approval at the shareholders' annual meeting on June 12, 2025 [1] - The maximum amount for the share buyback is set at HKD 20 million [1] Rationale for Buyback - The board believes that the current trading price does not accurately reflect the company's intrinsic value [1] - The share buyback is seen as a demonstration of the company's confidence in its business prospects and aims to create value for shareholders [1] Financial Position - The board is confident that the company's current financial resources are sufficient to support the proposed share buyback while maintaining a robust financial position [1]
康宁杰瑞制药-B(09966)拟进行场内股份购回